Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25366297 | 1.00 | FKBP1A (0.31) | FKBP1ATOP2A | |
| SCHEMBL2842945 | 0.87 | ALDH1A1 (0.36) | FKBP1A | |
| SCHEMBL2842338 | 0.87 | ALDH1A1 (0.36) | FKBP1A | |
| SCHEMBL2838596 | 0.87 | ALDH1A1 (0.36) | FKBP1A | |
| SCHEMBL27190406 | 0.85 | TOP2A (0.34) | FKBP1ATOP2A | |
| SCHEMBL5497614 | 0.82 | CYP19A1 (0.34) | — | |
| SCHEMBL5497620 | 0.82 | CYP19A1 (0.34) | — | |
| SCHEMBL4214203 | 0.81 | FKBP1A (0.33) | FKBP1ATOP2A | |
| SCHEMBL2957842 | 0.81 | FKBP1A (0.33) | FKBP1ATOP2A | |
| SCHEMBL4972513 | 0.81 | FKBP1A (0.33) | FKBP1ATOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183405-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-4216946-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-116437913-A | Pharmaceutical compounds for treating complement-mediated disorders | 艾其林医药公司 | 2023-07-14 | — | — | CN | disclosed |